Jafaru Abu

Dr. Jafaru Abu

Consultant Gynecological Oncology Surgeon

Years of Experience : 20

Nationality : United Kigdom

Languages Known : English, Arabic

Book Appointment


Dr. Jafaru Abu is a renowned Consultant Gynecological Oncology Surgeon with nearly 20 years of extensive work in the Obestetrics and Gynecology specialty across leading hospitals in the UK. Dr. Abu is well known for his exceptional ability to perform complex key-hole procedures both laparoscopically and with the DaVinci Robot and, for performing extensive surgery for advanced stages of ovarian cancer. He was one of the first gynecologists in the UK to perform Single Incision Laparoscopic Surgery (SILS), a scarless procedure. Dr. Abu was appointed as a Consultant Gynecological Oncology Surgeon and Head of the Department at Nottingham University Hospital, UK, where he led a major transformation in the surgical management of gynecological cancers. He pioneered the introduction of several surgical procedures for the management of cancers of the womb, cervix and early stages of ovarian cancer. Later, The Department of Gynecological Oncology became an Accredited Advanced Ovarian Cancer Cytoreductive Surgical Centre by The European Society of Gynecological Oncologists (ESGO). He was also a Visiting Fellow to the Centre of Gynecological Cancers and Minimally Invasive Surgery, Royal Brisbane Hospital & the Royal Women’s Hospital, Queensland, Australia, and The Royal Northshore Hospital Sydney, Australia. Dr. Jafaru Abu has received several awards for his outstanding work. A landmark achievement in his career has been the entry he gained in the Who’s Who in Medicine and Healthcare in 2009.

Awards & Achievements

  • RCOG Ethicon Travel Award
  • Hospital Doctor Merit Award for the One-Stop Menstrual Clinic at University Hospitals of Leicester, UK
  • First Position Award from The Royal Society of Medicine, Registrars' Prize Meeting in Obstetrics and Gynecology
  • First Prize for Joint RCOG and the Trinidad Society of Obstetrics and Gynecology Meeting


  • All Diagnosed or Suspected Gynecological Cancers, Including; Cervical Cancers, Uterine or Womb Cancers, Ovarian Cancers, and Vaginal Cancers
  • Ovarian and Vaginal Masses
  • Irregular Menstrual Bleeding, Postmenopausal Bleeding and Abnormal Uterine Bleeding
  • Abnormal PAP Smears
  • Suspicious Vulvar and Cervical Lesions
  • Uterine Fibroids
  • Keyhole Hysterectomy (Laparoscopic or Robot-Assisted)
  • Cytoreductive Surgery (Ultraradical Surgery) for Advanced Stages of Ovarian Cancer
  • Pelvic and Para-Aortic Lymphadenectomy (Open/Laparoscopic/Robotic)
  • Radical Hysterectomy (Open/Laparoscopic/Robotic)
  • Pelvic Exenteration Surgery for Locally Recurrent Gynecological Cancers
  • Fertility Preservation Surgery for Cervical Cancer (Trachelectomy - Simple or Radical)
  • Ovarian Transposition Procedures (Laparoscopic or Robotic)
  • Sentinel Lymph Nodes for Cervical and Endometrial Cancers (Laparoscopic or Robotic)
  • Sentinel Lymph Nodes for Vulvar Cancer


  • Royal College of Obstetricians and Gynecologists (RCOG)
  • British Society for Colposcopy and Cervical Pathology (BSCCP)
  • British Gynecological Cancer Society (BGCS)
  • Formerly a Member of the Subspecialty Training Council of the BGCS
  • International Gynecological Cancer Society (IGCS)
  • European Society of Gynecological Oncologists (ESGO)
  • European Society of Gynecological Endoscopists (ESGE)
  • British and Irish Association of Robotic Gynecologists (BIARGS)
  • British Medical Association (BMA)
  • Medical Staffing Research Committee, Nottingham University Hospital (MSRC)


Other Obstetrics & Gynecology Experts

Walid El-Sherbiny
Mai Mohammed Elsayed
Niveen Mohammad Hussein
Eman Samir Mohamed Ibrahim

Medeor Abu Dhabi Specialties